RG62 Compre Grp.28

TIDMRG62

RNS Number : 2089X

Compre Group Holdings Limited

25 August 2022

Press release

25 August 2022

Compre acquires further MedMal portfolio

Compre Group Holdings Limited ("Compre"), the Bermuda headquartered international legacy group, today announces it has received regulatory approval to acquire the French medical malpractice ("MedMal") portfolio from a European based insurer for an undisclosed sum.

The deal, structured as a loss portfolio transfer to be followed by a legal transfer, is a further significant transaction that supports Compre's ambition to build a centre of excellence for MedMal in Europe. The portfolio contains legacy, live and prospective risks through 2023. The transaction was brokered by Guy Carpenter.

Simon Hawkins, CEO Europe said: "I am delighted to announce our second acquisition of European MedMal legacy liabilities. We worked closely with the insurer to ensure the structure optimises capital release and provides operational finality. This transaction further demonstrates our client-focused approach, which ensured our client's objectives were realised, and our commitment to building a centre of excellence for MedMal in Europe."

- Ends -

For further information please contact:

Compre

David Haggie / Richard Adams / Olivia Thomson, Haggie Partners

+44 20 7562 4444

About Compre:

Compre is a leading legacy specialist with over 30 years of experience in the acquisition and management of discontinued and legacy non-life insurance and reinsurance business. Compre has experience of acquiring most classes of direct and reinsurance business, including general liability, marine and motor liability, and US APH. Compre has operations in Bermuda, Finland, Germany, Malta, Switzerland, the UK, US and at Lloyd's of London.

www.compre-group.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CIREAXPSAAEAEEA

(END) Dow Jones Newswires

August 25, 2022 03:22 ET (07:22 GMT)

Compre Grp.28 (LSE:RG62)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Compre Grp.28 (LSE:RG62)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024